Ads
related to: lung cancer- SCLC Patient Video
Watch an SCLC Patient Video &
Learn More About An SCLC Treatment.
- Financial Assistance
Learn About Your Options That May
Help You Afford A SCLC Treatment.
- Sign Up For Your Kit
Sign Up To Receive A Welcome Kit &
Guide For A Treatment Program.
- Infusion & Safety Info
See Dosing, Administration, &
Safety Info On an SCLC Treatment.
- Tips, Support & Safety
Caregivers Play An Important Role.
See Info & Tips For Caregivers.
- About SCLC
Learn About Lung Cancer Symptoms &
Explore Your Treatment Options.
- SCLC Patient Video
Search results
Strong Trial Results For Pfizer Lung Cancer Drug
International Business Times· 6 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung ...
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 6 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...
Stress from living in violent neighborhoods tied to aggressive lung cancer in Black men
Medical Xpress· 3 days agoExposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR)...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 6 days agoInc.’s blockbuster Keytruda in a late-stage clinical trial. The trial compared the Summit drug,...
Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer
MedPage Today· 4 days agoEarly palliative care delivered via video was as effective as in-person visits on quality-of-life...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 6 days agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 2 days agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung
Newswise Expert | Narjust Florez, Dana-Farber Cancer Institute
Newswise· 1 day agoDr. Narjust Florez is the Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. Dr. Florez's clinical interests include ...
Gilead’s Trodelvy extends lung cancer survival by just 1.3 months in trial
WHTC 1450 Holland· 6 days agoBy Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than...
Strong trial results for Pfizer lung cancer drug
The Raw Story· 5 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung ...
Ad
related to: lung cancer